Search details
1.
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
Am J Hematol
; 97(9): 1159-1169, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35726449
2.
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma
Haematologica
; 106(12): 3170-3175, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-33147935
3.
Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population.
BMC Cancer
; 21(1): 566, 2021 May 17.
Article
in English
| MEDLINE | ID: mdl-34001056
4.
Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational study.
J Oncol Pharm Pract
; 25(5): 1042-1052, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-29554828
5.
Assessment of psychological distress among Asian adolescents and young adults (AYA) cancer patients using the distress thermometer: a prospective, longitudinal study.
Support Care Cancer
; 26(9): 3257-3266, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-29644471
6.
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study.
Lancet Oncol
; 17(9): 1240-7, 2016 Sep.
Article
in English
| MEDLINE | ID: mdl-27470079
7.
Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma.
Exp Hematol Oncol
; 13(1): 1, 2024 Jan 03.
Article
in English
| MEDLINE | ID: mdl-38173015
8.
Clinical pharmacy services and research for lymphoma patients at a cancer center.
J Oncol Pharm Pract
; 19(1): 24-30, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-22706787
9.
A response to the letter to the editor on "Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational study".
J Oncol Pharm Pract
; 24(6): 478-479, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29925294
10.
Burkitt lymphoma - no impact of HIV status on outcomes with rituximab-based chemoimmunotherapy.
Leuk Lymphoma
; 64(3): 586-596, 2023 03.
Article
in English
| MEDLINE | ID: mdl-35188049
11.
Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin's Lymphoma.
Hematol Rep
; 15(1): 108-118, 2023 Feb 10.
Article
in English
| MEDLINE | ID: mdl-36810555
12.
Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study.
Leuk Lymphoma
; 64(11): 1782-1791, 2023.
Article
in English
| MEDLINE | ID: mdl-37477443
13.
Sun exposure and risk of lymphoid neoplasms in Singapore.
Cancer Causes Control
; 23(7): 1055-64, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22543543
14.
Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres (pattern 1) shows superior survival to patterns 2 and 3: a meta-analysis of 56 cases.
Histopathology
; 60(4): 570-85, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-22251198
15.
A Prognostic Model Using Post-Steroid Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Primary Central Nervous System Lymphoma.
Cancers (Basel)
; 14(7)2022 Apr 03.
Article
in English
| MEDLINE | ID: mdl-35406590
16.
Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method.
Leuk Lymphoma
; 63(1): 256-259, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34665693
17.
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.
Cancer Rep (Hoboken)
; 5(9): e1552, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35481622
18.
Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin's lymphoma.
Ann Hematol
; 90(1): 67-72, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20676640
19.
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
Ann Hematol
; 90(10): 1219-23, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-21520001
20.
Breakthrough febrile neutropenia and associated complications in Non-Hodgkin's lymphoma patients receiving pegfilgrastim.
Acta Haematol
; 125(3): 107-14, 2011.
Article
in English
| MEDLINE | ID: mdl-21109731